Cetera Trust Company’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History
Bought
Maintained
Sold
Other funds holding QNTM
Cetera Trust Company's QNTM Position: Q3 2026 in Review
Cetera Trust Company held its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) position steady in Q3 2026 at 250 shares worth $900. The position accounts for ﹤0.01% of the portfolio, ranked #329.
Cetera Trust Company first reported a position in QNTM in Q1 2025 and has held it in 7 quarters since. The position peaked at $5.06K in Q2 2025. 27 funds tracked by Wall St. Rank hold QNTM as of Q3 2026.
- Cetera Trust Company held 250 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $900 as of Q3 2026.
- Cetera Trust Company left its Quantum Biopharma Class B Subordinate Voting Shares share count unchanged in Q3 2026.
- Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Cetera Trust Company's portfolio in Q3 2026, its #329 holding.
- Cetera Trust Company first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2025 and has held it in 7 quarters since.
- Cetera Trust Company's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $5.06K in Q2 2025.
- 27 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q3 2026.
Based on Cetera Trust Company's 13F filing for Q3 2026, filed 9 Nov 2026.